Dec 08, 2022 / 06:05PM GMT
Operator
(Operator Instructions) At this time, it is my pleasure to turn the program over to our host, Jason Gerberry.
Jason Matthew Gerberry - BofA Securities, Research Division - MD in US Equity Research
Thank you, and good day, everybody. Thanks for joining us at the Bank of America Biotech Virtual Conference here. My name is Jason Gerberry. I'm one of the Biotech Analyst and I'm pleased to be introducing FibroGen, our next company presenter and CEO, Enrique Conterno. Enrique, first off, just thanks for joining us.
Enrique A. Conterno - FibroGen, Inc. - CEO & Director
Well, thank you very much for the invitation, Jason.
Questions and Answers:
Jason Matthew Gerberry - BofA Securities, Research Division - MD in US Equity ResearchGreat, great. So I think it probably makes sense if we talk a little bit about pipeline first and then we can work our way backwards to some of the commercial elements of the FibroGen company story if that works for you. Maybe -- we'll start with